155 related articles for article (PubMed ID: 20168159)
21. Initial treatment and outcome of Candida glabrata versus Candida albicans bloodstream infection.
Klevay MJ; Horn DL; Neofytos D; Pfaller MA; Diekema DJ;
Diagn Microbiol Infect Dis; 2009 Jun; 64(2):152-7. PubMed ID: 19376667
[TBL] [Abstract][Full Text] [Related]
22. Fungemia associated with left ventricular assist device support.
Bagdasarian NG; Malani AN; Pagani FD; Malani PN
J Card Surg; 2009; 24(6):763-5. PubMed ID: 20078725
[TBL] [Abstract][Full Text] [Related]
23. Epidemiology and treatment of hematogenous candidiasis: a Brazilian perspective.
Colombo AL
Braz J Infect Dis; 2000 Jun; 4(3):113-8. PubMed ID: 10934493
[TBL] [Abstract][Full Text] [Related]
24. Candidemia before and during the fluconazole era: prevalence, type of species and approach to treatment in a tertiary care community hospital.
Baran J; Muckatira B; Khatib R
Scand J Infect Dis; 2001; 33(2):137-9. PubMed ID: 11233850
[TBL] [Abstract][Full Text] [Related]
25. [Epidemiology of fungemia in a university hospital; therapeutic incidence].
Pavese P; Brion JP; Lebeau B; Grillot R; Ambroise-Thomas P
Pathol Biol (Paris); 1999 May; 47(5):579-83. PubMed ID: 10418046
[TBL] [Abstract][Full Text] [Related]
26. Candidemia at selected Canadian sites: results from the Fungal Disease Registry, 1992-1994. Fungal Disease Registry of the Canadian Infectious Disease Society.
Yamamura DL; Rotstein C; Nicolle LE; Ioannou S
CMAJ; 1999 Feb; 160(4):493-9. PubMed ID: 10081465
[TBL] [Abstract][Full Text] [Related]
27. Azole resistance of Candida glabrata in a case of recurrent fungemia.
Posteraro B; Tumbarello M; La Sorda M; Spanu T; Trecarichi EM; De Bernardis F; Scoppettuolo G; Sanguinetti M; Fadda G
J Clin Microbiol; 2006 Aug; 44(8):3046-7. PubMed ID: 16891541
[TBL] [Abstract][Full Text] [Related]
28. A retrospective Evaluation of fluconazole for the treatment of Candida glabrata fungemia.
Wilson AG; Micek ST; Ritchie DJ
Clin Ther; 2005 Aug; 27(8):1228-37. PubMed ID: 16199247
[TBL] [Abstract][Full Text] [Related]
29. Candida parapsilosis fungemia in cancer patients--incidence, risk factors and outcome.
Krcméry V; Spánik S; Grausová S; Trupl J; Krupová I; Roidová A; Sálek T; Sufliarsky J; Mardiak J
Neoplasma; 1998; 45(5):336-42. PubMed ID: 9921924
[TBL] [Abstract][Full Text] [Related]
30. Increase in prevalence of nosocomial non-Candida albicans candidaemia and the association of Candida krusei with fluconazole use.
Hope W; Morton A; Eisen DP
J Hosp Infect; 2002 Jan; 50(1):56-65. PubMed ID: 11825053
[TBL] [Abstract][Full Text] [Related]
31. Changing pattern of candidaemia 2001-2006 and use of antifungal therapy at the University Hospital of Vienna, Austria.
Presterl E; Daxböck F; Graninger W; Willinger B
Clin Microbiol Infect; 2007 Nov; 13(11):1072-6. PubMed ID: 17725647
[TBL] [Abstract][Full Text] [Related]
32. Invasive candidiasis: turning risk into a practical prevention policy?
Sobel JD; Rex JH
Clin Infect Dis; 2001 Jul; 33(2):187-90. PubMed ID: 11418878
[No Abstract] [Full Text] [Related]
33. Epidemiological characteristics of fatal Candida krusei fungemia in immunocompromised febrile neutropenic children.
Agirbasli H; Otlu B; Bilgen H; Durmaz R; Gedikoglu G
Infection; 2008 Feb; 36(1):88-91. PubMed ID: 18084719
[No Abstract] [Full Text] [Related]
34. [Epidemiology of candidemia: a one-year prospective observational study in the west of France].
Talarmin JP; Boutoille D; Tattevin P; Dargère S; Weinbreck P; Ansart S; Chennebault JM; Hutin P; Léautez-Nainville S; Gay-Andrieu F; Raffi F;
Med Mal Infect; 2009 Dec; 39(12):877-85. PubMed ID: 19346088
[TBL] [Abstract][Full Text] [Related]
35. Antifungal drug resistance: limited data, dramatic impact?
Rogers TR
Int J Antimicrob Agents; 2006 Jun; 27 Suppl 1():7-11. PubMed ID: 16701982
[TBL] [Abstract][Full Text] [Related]
36. Secular trends in nosocomial candidaemia in non-neutropenic patients in an Italian tertiary hospital.
Luzzati R; Allegranzi B; Antozzi L; Masala L; Pegoraro E; Azzini A; Concia E
Clin Microbiol Infect; 2005 Nov; 11(11):908-13. PubMed ID: 16216107
[TBL] [Abstract][Full Text] [Related]
37. Changing patterns and trends in systemic fungal infections.
Richardson MD
J Antimicrob Chemother; 2005 Sep; 56 Suppl 1():i5-i11. PubMed ID: 16120635
[TBL] [Abstract][Full Text] [Related]
38. Recent experience with fungaemia: change in species distribution and azole resistance.
Chakrabarti A; Chatterjee SS; Rao KL; Zameer MM; Shivaprakash MR; Singhi S; Singh R; Varma SC
Scand J Infect Dis; 2009; 41(4):275-84. PubMed ID: 19229762
[TBL] [Abstract][Full Text] [Related]
39. Candidemia in neonatal intensive care unit.
Gupta N; Mittal N; Sood P; Kumar S; Kaur R; Mathur MD
Indian J Pathol Microbiol; 2001 Jan; 44(1):45-8. PubMed ID: 12561995
[TBL] [Abstract][Full Text] [Related]
40. Incidence of candidaemia and relationship with fluconazole use in an intensive care unit.
Bassetti M; Ansaldi F; Nicolini L; Malfatto E; Molinari MP; Mussap M; Rebesco B; Bobbio Pallavicini F; Icardi G; Viscoli C
J Antimicrob Chemother; 2009 Sep; 64(3):625-9. PubMed ID: 19622536
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]